Clinical trial
Rolandic Epilepsy Genomewide Association International Study
NCT03547050 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rolandic Epilepsy Genomewide Association International Study
- Lead sponsor
- King's College London
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2018
- Completion date
- June 30, 2023
- Enrollment
- 210 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
rolandic epilepsy